<unk> , also known as dehydroepiandrosterone<unk>  (DHEA-E) and sold in combination with estradiol valerate under the brand name Gynodian Depot among others, is a weak androgen, estrogen, and neurosteroid medication which is used as a component of menopausal hormone therapy to treat menopausal symptoms in women. It is available only as an injectable preparation in combination with estradiol valerate. The medication is given by injection into muscle typically once ever 4 weeks.<unk>  is a synthetic androgen, estrogen, and neurosteroid. It is a steroid ester and a long-lasting prodrug of<unk>  (dehydroepiandrosterone; DHEA) in the body.<unk>  is a naturally occurring prohormone of androgens and estrogens and hence is an agonist of the androgen and estrogen receptors, the respective biological targets of androgens like testosterone and estrogens like estradiol.<unk>  also has a variety of activities of its own, including neurosteroid and other activities. An injection of<unk>  has a duration of action in terms of elevated<unk>  levels of about 18 days. The combination of estradiol valerate and<unk>  was developed as early as 1966 and was introduced for medical use in 1975. The formulation is marketed widely throughout Europe, and is also available in several Latin American countries and in Egypt. It is not available in any predominantly English-speaking countries.
Prasterone enanthate
Prasterone sulfate
Oxabolone cipionate
Bolandiol dipropionate
Etynodiol diacetate
Methestrol dipropionate
Gestonorone caproate
Oxyprothepin decanoate